PGmax™ - Comprehensive Movement Disorders Panel
Use
This test is designed for individuals with features indicative of movement disorders, such as ataxia, dystonia, tremor, and parkinsonism. It is ideal for those with a clinical or suspected diagnosis of a movement disorder and those with a family history of hereditary movement disorders. The comprehensive panel covers a wide array of genetic conditions associated with various movement disorders, aiming to provide pivotal insights for diagnosis and management.
Special Instructions
Not provided.
Limitations
This panel includes 938 genes related to movement disorders, but it may not detect all mutations associated with every possible hereditary movement disorder. Variants of unknown significance may be reported, and the interpretation of variants is dependent on the quality of clinical information provided. Results are based on the NGS technology and are subject to its inherent limitations, including sequencing errors and mapping issues.
New York Approved
Methodology
NGS
Biomarkers
Result Turnaround Time
14-28 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided